Free Trial
NASDAQ:AKYA

Akoya Biosciences (AKYA) Stock Price, News & Analysis

Akoya Biosciences logo
$1.37 +0.02 (+1.41%)
Closing price 07/3/2025 02:39 PM Eastern
Extended Trading
$1.37 +0.01 (+0.37%)
As of 07/3/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Akoya Biosciences Stock (NASDAQ:AKYA)

Key Stats

Today's Range
$1.35
$1.40
50-Day Range
$0.95
$1.37
52-Week Range
$0.93
$3.42
Volume
309,669 shs
Average Volume
403,764 shs
Market Capitalization
$68.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.51
Consensus Rating
Hold

Company Overview

Akoya Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

AKYA MarketRank™: 

Akoya Biosciences scored higher than 42% of companies evaluated by MarketBeat, and ranked 619th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Akoya Biosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Akoya Biosciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about Akoya Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Akoya Biosciences are expected to grow in the coming year, from ($0.96) to ($0.64) per share.

  • Price to Book Value per Share Ratio

    Akoya Biosciences has a P/B Ratio of 9.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Akoya Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    12.67% of the float of Akoya Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Akoya Biosciences has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Akoya Biosciences has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Akoya Biosciences does not currently pay a dividend.

  • Dividend Growth

    Akoya Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.67% of the float of Akoya Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Akoya Biosciences has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Akoya Biosciences has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Akoya Biosciences insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 7.30% of the stock of Akoya Biosciences is held by insiders.

    • Percentage Held by Institutions

      79.42% of the stock of Akoya Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Akoya Biosciences' insider trading history.
    Receive AKYA Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.

    AKYA Stock News Headlines

    AKYA Akoya Biosciences, Inc. - Seeking Alpha
    Brokerages Set Akoya Biosciences, Inc. (NASDAQ:AKYA) PT at $2.51
    Elon’s BIGGEST warning yet?
    Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
    See More Headlines

    AKYA Stock Analysis - Frequently Asked Questions

    Akoya Biosciences' stock was trading at $2.29 at the beginning of the year. Since then, AKYA shares have decreased by 40.2% and is now trading at $1.3690.

    Akoya Biosciences, Inc. (NASDAQ:AKYA) issued its quarterly earnings data on Monday, May, 12th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by $0.03. The company earned $16.64 million during the quarter, compared to analysts' expectations of $20.19 million. Akoya Biosciences had a negative net margin of 59.44% and a negative trailing twelve-month return on equity of 487.85%.

    Akoya Biosciences (AKYA) raised $125 million in an IPO on Friday, April 16th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share. J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity acted as the underwriters for the IPO.

    Shares of AKYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Akoya Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Broadcom (AVGO), Invesco QQQ (QQQ) and Palo Alto Networks (PANW).

    Company Calendar

    Last Earnings
    5/12/2025
    Today
    7/06/2025
    Next Earnings (Estimated)
    8/04/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Measuring And Control Equipment
    Current Symbol
    NASDAQ:AKYA
    Fax
    N/A
    Employees
    90
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $2.51
    High Stock Price Target
    $5.00
    Low Stock Price Target
    $1.08
    Potential Upside/Downside
    +83.1%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    7 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$55.37 million
    Pretax Margin
    -59.28%

    Debt

    Sales & Book Value

    Annual Sales
    $81.67 million
    Price / Cash Flow
    N/A
    Book Value
    $0.15 per share
    Price / Book
    9.13

    Miscellaneous

    Free Float
    46,307,000
    Market Cap
    $68.38 million
    Optionable
    Optionable
    Beta
    1.36
    20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

    Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

    Get This Free Report

    This page (NASDAQ:AKYA) was last updated on 7/6/2025 by MarketBeat.com Staff
    From Our Partners